Je was op zoek naar: pugh (Deens - Engels)

dr. mike pugh«
dr mike pugh’

pugh score 6.
score 6.

child- pugh a).
32 patients with hepatic impairment in patients with compensated cirrhosis (eg, child-pugh a), pegasys has been shown to be effective and safe.

traktion ad modum pugh
pugh traction

child- pugh score ≥ 6.
child-pugh score ≥ 6.

svær leverfunktionsnedsættelse (child pugh c).
severe hepatic impairment (child pugh c).

patienter med child-pugh c leversygdom
patients with child-pugh c liver disease

child- pugh class a eller b).
child-pugh class a and b).

svært nedsat leverfunktion (child pugh c)
severe hepatic impairment (child pugh c)

satserne er baseret på child-pugh-klassificeringen:
ratings are based on the child-pugh scoring system:

deres child- pugh score bør vurderes under behandling.
co-infected patients receiving both antiretroviral (arv) and anti-hepatitis treatment should be closely monitored, assessing their child-pugh score during treatment.

-patienter med svær leversygdom (child-pugh 9) .
-patients with severe hepatic disease (child-pugh 9) .

svært nedsat leverfunktion (child pugh-klasse c).
severe hepatic impairment (child pugh class c).

til voksne med let nedsat leverfunktion (child-pugh score:
for adults with mild hepatic impairment (child-pugh score:

svær leverdysfunktion (serumalbumin 25 g/l eller child pugh score 10)
severe hepatic dysfunction (serum albumin 25 g/l or child-pugh score 10) .

moderat leversygdom (child- pugh- gruppe b) påvirkede duloxetins farmakokinetik.
hepatic impairment: moderate liver disease (child pugh class b) affected the pharmacokinetics of duloxetine.

cpt- (child-pugh-turcotte) klasse b- cirrose før transplantation
child-pugh-turcotte (cpt) class b cirrhosis pre-transplant

nedsat leverfunktion: moderat leversygdom (child-pugh-gruppe b) påvirkede duloxetins farmakokinetik.
hepatic impairment: moderate liver disease (child pugh class b) affected the pharmacokinetics of duloxetine.